MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience
Purpose: Evaluate the role of multi-detector computed tomography (MDCT) in follow up HCC patients after radiofrequency ablation. Materials and methods: A prospective study was used to assess patients who underwent radiofrequency ablation for treatment of HCC nodules using MDCT. MDCT was done immedia...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2014-06-01
|
| Series: | The Egyptian Journal of Radiology and Nuclear Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0378603X1400031X |
| _version_ | 1818926723460235264 |
|---|---|
| author | Nadia F. El Ameen Hosny S. Abdel Ghany Mostafa M. Elian Tamer El Zaeem |
| author_facet | Nadia F. El Ameen Hosny S. Abdel Ghany Mostafa M. Elian Tamer El Zaeem |
| author_sort | Nadia F. El Ameen |
| collection | DOAJ |
| description | Purpose: Evaluate the role of multi-detector computed tomography (MDCT) in follow up HCC patients after radiofrequency ablation.
Materials and methods: A prospective study was used to assess patients who underwent radiofrequency ablation for treatment of HCC nodules using MDCT. MDCT was done immediately after procedure to asses treatment success, then after one month for decision making; either good ablation or reablation for residual tumor if present. Three and six months follow up for detection of marginal growth or newly developed HCC nodules. One year MDCT follow up for true technical success.
Results: MDCT findings were as follows: immediate evaluation showed good ablation in 29 patients (96.7%), and one patient showed residual tumor tissue reablated at the same session. In one month follow up nodular marginal enhancement denoting residual tumor was seen in 2 patients (6.7%). In three months follow up no residual tumor or recurrence (100%); in six months follow up recurrence was seen in one patient (3.4%) and another patient (3.4%) showed a new HCC focus. In one year follow up marginal recurrence was seen in three patients (10%).
Conclusion: RF ablation is an internationally approved treatment for HCC. MDCT should be the corner stone method for follow to achieve better results and improve the survival rate via early detection and immediate interference with any new or recurrent lesions. |
| first_indexed | 2024-12-20T03:01:39Z |
| format | Article |
| id | doaj.art-cfa8ba4b2c234f209d40be6a1743ab64 |
| institution | Directory Open Access Journal |
| issn | 0378-603X |
| language | English |
| last_indexed | 2024-12-20T03:01:39Z |
| publishDate | 2014-06-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | The Egyptian Journal of Radiology and Nuclear Medicine |
| spelling | doaj.art-cfa8ba4b2c234f209d40be6a1743ab642022-12-21T19:55:43ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine0378-603X2014-06-0145240941510.1016/j.ejrnm.2014.02.003MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experienceNadia F. El Ameen0Hosny S. Abdel Ghany1Mostafa M. Elian2Tamer El Zaeem3Department of Radiology, El Minia University Hospital, Minia Faculty of Medicine, EgyptDepartment of Radiology, El Minia University Hospital, Minia Faculty of Medicine, EgyptDepartment of Radiology, El Minia University Hospital, Minia Faculty of Medicine, EgyptDepartment of Radiology, El Minia University Hospital, El Minia, EgyptPurpose: Evaluate the role of multi-detector computed tomography (MDCT) in follow up HCC patients after radiofrequency ablation. Materials and methods: A prospective study was used to assess patients who underwent radiofrequency ablation for treatment of HCC nodules using MDCT. MDCT was done immediately after procedure to asses treatment success, then after one month for decision making; either good ablation or reablation for residual tumor if present. Three and six months follow up for detection of marginal growth or newly developed HCC nodules. One year MDCT follow up for true technical success. Results: MDCT findings were as follows: immediate evaluation showed good ablation in 29 patients (96.7%), and one patient showed residual tumor tissue reablated at the same session. In one month follow up nodular marginal enhancement denoting residual tumor was seen in 2 patients (6.7%). In three months follow up no residual tumor or recurrence (100%); in six months follow up recurrence was seen in one patient (3.4%) and another patient (3.4%) showed a new HCC focus. In one year follow up marginal recurrence was seen in three patients (10%). Conclusion: RF ablation is an internationally approved treatment for HCC. MDCT should be the corner stone method for follow to achieve better results and improve the survival rate via early detection and immediate interference with any new or recurrent lesions.http://www.sciencedirect.com/science/article/pii/S0378603X1400031XHepatocellular carcinomas (HCC)RF ablationMDCT |
| spellingShingle | Nadia F. El Ameen Hosny S. Abdel Ghany Mostafa M. Elian Tamer El Zaeem MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience The Egyptian Journal of Radiology and Nuclear Medicine Hepatocellular carcinomas (HCC) RF ablation MDCT |
| title | MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience |
| title_full | MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience |
| title_fullStr | MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience |
| title_full_unstemmed | MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience |
| title_short | MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience |
| title_sort | mdct assessment of hcc patient after radiofrequency ablation among egyptian population preliminary experience |
| topic | Hepatocellular carcinomas (HCC) RF ablation MDCT |
| url | http://www.sciencedirect.com/science/article/pii/S0378603X1400031X |
| work_keys_str_mv | AT nadiafelameen mdctassessmentofhccpatientafterradiofrequencyablationamongegyptianpopulationpreliminaryexperience AT hosnysabdelghany mdctassessmentofhccpatientafterradiofrequencyablationamongegyptianpopulationpreliminaryexperience AT mostafamelian mdctassessmentofhccpatientafterradiofrequencyablationamongegyptianpopulationpreliminaryexperience AT tamerelzaeem mdctassessmentofhccpatientafterradiofrequencyablationamongegyptianpopulationpreliminaryexperience |